FUNIOTCServices-Testing LaboratoriesFiscal year ends September 30
Hypha Labs, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.00−0.00 (-4.55%)
Close on Oct 19, 2026
- Market cap
- $688.36K
- P/E (TTM)
- –
- Dividend yield
- –
Hypha Labs, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q3 15 | Q2 15 | Q1 15 | Q4 14 | Q3 14 | Q2 14 | Q1 14 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Microscopy [Member] | $5.29K | $122.95K | $171.51K | $163.08K | $217.25K | $50.60K | $54.94K | 76.6% | -97.6% |
| Cannabis [Member] | $1.62K | $13.50K | $2.25K | – | – | – | $0 | 23.4% | – |
From the segment and revenue-disaggregation notes of Hypha Labs's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.